Stockscreener 앱 받기
82.12
1.24%
1.05
전일 마감가:
$81.07
열려 있는:
$81.52
하루 거래량:
3.06M
Relative Volume:
0.41
시가총액:
$104.17B
수익:
$386.46B
순이익/손실:
$4.49B
주가수익비율:
22.91
EPS:
3.5841
순현금흐름:
$4.78B
1주 성능:
-0.54%
1개월 성능:
+7.45%
6개월 성능:
+24.50%
1년 성능:
+46.25%
1일 변동 폭
$81.08
$82.14
1주일 범위
$80.51
$83.52
52주 변동 폭
$43.56
$83.52
CVS헬스 Stock (CVS) Company Profile
명칭
Cvs Health Corp
전화
(401) 765-1500
주소
ONE CVS DR., WOONSOCKET
CVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
82.13 | 102.82B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
364.34 | 326.45B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CI
Cigna Group
|
302.23 | 81.43B | 261.22B | 5.40B | 3.94B | 18.31 |
|
ELV
Elevance Health Inc
|
343.71 | 76.96B | 194.82B | 5.53B | 5.34B | 24.45 |
|
HUM
Humana Inc
|
288.57 | 35.04B | 123.11B | 1.58B | 2.44B | 13.03 |
CVS헬스 Stock (CVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-14 | 개시 | Goldman | Buy |
| 2025-08-18 | 업그레이드 | UBS | Neutral → Buy |
| 2025-08-14 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Edward Jones | Hold → Buy |
| 2024-12-03 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-11-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-10-04 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-05-30 | 개시 | Robert W. Baird | Neutral |
| 2024-05-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-05-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-12-22 | 개시 | HSBC Securities | Buy |
| 2023-09-19 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-09-12 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
| 2023-05-26 | 개시 | Piper Sandler | Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 재개 | Morgan Stanley | Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-02-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 개시 | Goldman | Buy |
| 2021-12-01 | 개시 | Seaport Research Partners | Buy |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-01-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-09-17 | 개시 | Piper Sandler | Overweight |
| 2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
| 2020-05-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 재개 | RBC Capital Mkts | Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Buy |
| 2019-06-05 | 업그레이드 | Standpoint Research | Hold → Buy |
| 2019-04-29 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 개시 | Guggenheim | Buy |
| 2019-04-15 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 재확인 | BofA/Merrill | Buy |
| 2019-03-13 | 개시 | Bernstein | Outperform |
| 2019-02-20 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-18 | 개시 | Barclays | Overweight |
| 2018-11-29 | 재개 | Goldman | Neutral |
| 2018-11-28 | 개시 | Evercore ISI | Outperform |
| 2018-10-26 | 재개 | Wolfe Research | Peer Perform |
| 2018-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-02-27 | 재개 | BofA/Merrill | Buy |
| 2018-02-13 | 재확인 | Citigroup | Neutral |
모두보기
CVS헬스 주식(CVS)의 최신 뉴스
UBS Raises Price Target for CVS Health to $96 | CVS Stock News - GuruFocus
CVS Health Corp. Experiences Revision in Score Amidst Market Performance Evaluation - Markets Mojo
Using Python tools to backtest CVS Health Corporation strategiesStop Loss & Capital Efficient Trade Techniques - newser.com
Why CVS Health Corporation (CVS) stock could outperform next yearGap Down & Smart Money Movement Alerts - newser.com
How to build a custom watchlist for CVS Health CorporationProduct Launch & High Return Trade Opportunity Guides - newser.com
Using Bollinger Bands to evaluate CVS Health CorporationWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - newser.com
CVS Health (CVS) Valuation in Focus Following Medicaid Margin and Contract Loss Concerns - Yahoo Finance
CVS (CVS) Delays Adding Gilead's Yeztugo Over Pricing Concerns - GuruFocus
CVS aims for Q3 momentum amid industry challenges - The Business Journals
CVS Caremark tells AIDS activists Gilead needs to lower the price of its new HIV drug to get on formularies - statnews.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CT company launches new round of layoffs. Here’s how they affect the state. - Hartford Courant
CVS Health’s Quarterly Earnings Preview: What You Need to Know - Barchart.com
CVS Health Corp (NYSE:CVS) Stock Quote - FinancialContent
Why global investors buy CVS Health Corporation stockMarket Trend Review & Weekly Momentum Stock Picks - newser.com
Why CVS Health Corporation (CVS) stock stays on top picksQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
HLTH 2025, Day 3: Health systems weigh AI’s promise against risks - Modern Healthcare
HLTH 2025, Day 4: UPMC eyes AI to boost recruitment - Modern Healthcare
Is CVS Health Corporation Common Stock CVS0 a good long term investmentInsider Buying Signals & Access Our Free Weekly Investment Letter - earlytimes.in
How CVS Health Corporation (Common Stock) (CVS0) stock compares with top peersSell Signal & Real-Time Volume Trigger Notifications - newser.com
CVS says ‘system outage’ impacting some pharmacies - WJBF
CVS says ‘system outage’ resolved, but delays may still occur - KTLA
CVS dealing with ‘known system outage’ impacting pharmacies - ConchoValleyHomepage.com
CVS or HQY: Which Is the Better Value Stock Right Now? - Yahoo Finance
Cvs stock hits 52-week high at 82.88 USD By Investing.com - Investing.com South Africa
Cvs stock hits 52-week high at 82.88 USD - Investing.com
Lobbying Update: $2,150,000 of CVS HEALTH (AND SUBSIDIARIES) lobbying was just disclosed - Quiver Quantitative
Short interest data insights for CVS Health CorporationQuarterly Profit Summary & High Accuracy Swing Trade Signals - newser.com
How CVS Health Corporation (CVS) stock reacts to monetary easingWeekly Profit Analysis & Fast Entry Momentum Alerts - newser.com
Will CVS Health Corporation stock deliver stable dividendsCEO Change & Fast Momentum Stock Entry Tips - newser.com
CVS completes conversions of former Rite Aid, Bartell stores - The Business Journals
Measuring CVS Health Corporation’s beta against major indicesJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
CVS Health Corp. Hits New 52-Week High at $79.94 - Markets Mojo
CVS Health Corp. Hits New 52-Week High of $79.67 - Markets Mojo
Earnings Report: Will CVS Health Corporation stock continue dividend increasesWeekly Investment Recap & Real-Time Chart Pattern Alerts - nchmf.gov.vn
Will CVS Health Corporation stock sustain uptrend momentumGold Moves & High Accuracy Swing Trade Signals - nchmf.gov.vn
Will CVS Health Corporation stock outperform tech sector in 2025Earnings Growth Report & AI Driven Stock Price Forecasts - nchmf.gov.vn
CVS Can't Dodge Tobacco Surcharge Suit, Employee Says - Law360
Is CVS Health Corporation (Common Stock) (CVS0) stock undervalued historicallyWeekly Stock Recap & Weekly High Return Stock Opportunities - nchmf.gov.vn
Omnicare pharmacy to close Sacramento facility, laying off 64 employees - The Business Journals
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know - Yahoo
Notable Friday Option Activity: INTC, DIS, CVS - Nasdaq
CVS Health (CVS) Completes Acquisition of Rite Aid Assets to Exp - GuruFocus
CVS헬스 (CVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
2.12%
자본화:
|
볼륨(24시간):